Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"Effectiveness After Four and Twentyfour Weeks and Safety of Tocilizumab in Patients With Active RA"

NCT00754559 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT00754559
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00754559 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"Effectiveness After Four and Twentyfour Weeks and Safety of Tocilizumab in Patients With Active RA"
Lead sponsor
Hoffmann-La Roche
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2008
Completion date
November 30, 2009
Enrollment
286 (actual)
Sites
81

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis